stock
MDGL · MADRIGAL PHARMACEUTICALS, INC.
What MADRIGAL PHARMACEUTICALS, INC. reports to the SEC, read from its filings.
Open in the appPrice
The live MDGL price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on MDGL.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 23,104,126 as of 2026-07-27 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -25.1%
- Net
- -25.3%
Returns
- ROE
- -62.1%
- ROA
- -26.1%
Health
- Current ratio
- 3.2x
- Debt/equity
- 0.7x
Deep value
- NCAV
- $478.26M
- NCAV per share
- $20.70
- Price/NCAV
- Locked
- NNWC
- -$234.27M
- NNWC per share
- -$10.14
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $364.25M | —Gross profit: unreported by this company. | -$56.31M | -$57.94M | 10-Q filed 2026-07-30 |
| 2026-03-31 | $311.34M | —Gross profit: unreported by this company. | -$92.72M | -$94.39M | 10-Q filed 2026-07-30 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $321.08M | —Gross profit: unreported by this company. | -$59.61M | -$58.58M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $287.27M | —Gross profit: unreported by this company. | -$113.97M | -$114.19M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $212.80M | —Gross profit: unreported by this company. | -$47.20M | -$42.28M | 10-Q filed 2026-07-30 |
| 2025-03-31 | $137.25M | —Gross profit: unreported by this company. | -$79.31M | -$73.24M | 10-Q filed 2026-07-30 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $103.32M | —Gross profit: unreported by this company. | -$67.00M | -$59.42M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $62.17M | —Gross profit: unreported by this company. | -$116.30M | -$106.96M | 10-Q filed 2025-11-04 |
- Assets
- $1.24B
- Equity
- $523.72M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $958.40M | -$300.10M | -$288.28M | -$190.02M |
| 2024-12-31 | $180.13M | -$497.88M | -$465.89M | -$457.03M |
| 2023-12-31 | $0 | -$380.50M | -$373.63M | -$325.71M |
| 2022-12-31 | $0 | -$293.57M | -$295.25M | -$225.07M |
| 2021-12-31 | $0 | -$242.48M | -$241.85M | -$184.13M |
| 2020-12-31 | $0 | -$206.67M | -$202.24M | -$157.90M |
| 2019-12-31 | $0 | -$94.97M | -$83.95M | -$41.80M |
| 2018-12-31 | $0 | -$40.68M | -$32.81M | -$25.53M |
| 2017-12-31 | $0 | -$32.06M | -$31.15M | -$22.44M |
| 2016-12-31 | — | -$25.22M | -$26.39M | -$17.61M |
Company filings
events
Executive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureAug 128-KResults
ResultsJul 308-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 178-KResults
ResultsMay 68-KExecutive or director change
Executive or director changeApr 288-KResults
ResultsFeb 198-K
5% owners ()
BlackRock, Inc.
Stake update
PAULSON & CO. INC.
Stake update
JANUS HENDERSON GROUP PLC
Stake update
The Vanguard Group
Stake update
PAULSON & CO. INC.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Sibold William John
President and CEO, Director
Sale$6,239,198Sep 11, 4:57 PM ET
Kelley Shannon T
General Counsel
Sale$341,940Aug 20, 4:20 PM ET
Sibold William John
President and CEO, Director
Sale$1,368,253Jul 20, 9:16 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Paulson & Co
Period Tue 30 Jun 2026
27.9%Trimmed - Point72
Period Tue 30 Jun 2026
0.1%Trimmed - Point72
Calls · Period Tue 30 Jun 2026
0.0%Trimmed - Point72
Puts · Period Tue 30 Jun 2026
0.0%Trimmed
News
Stories that named MDGL, and the market events around them.
Sign in to see thisBoard
The MDGL board could not be loaded.
Retry the MDGL boardnakagai
Signals on MDGL come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the MDGL board